The effectiveness of inpatient and outpatient treatment for alcohol abuse: the need to focus on mediators and moderators of setting effects.
about
A blocker of N- and T-type voltage-gated calcium channels attenuates ethanol-induced intoxication, place preference, self-administration, and reinstatementMedication treatment of different types of alcoholism.Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings.The α1-adrenergic receptor antagonist, doxazosin, reduces alcohol drinking in alcohol-preferring (P) Rats.The continuing care model of substance use treatment: what works, and when is "enough," "enough?".Combining the α1 -adrenergic receptor antagonist, prazosin, with the β-adrenergic receptor antagonist, propranolol, reduces alcohol drinking more effectively than either drug alone.Neurophysiological correlates of response inhibition predict relapse in detoxified alcoholic patients: some preliminary evidence from event-related potentials.Predictors of motivation for abstinence at the end of outpatient substance abuse treatmentSubstance abuse intensive outpatient programs: assessing the evidence.Treatment setting and follow-up in alcohol dependenceThe pharmacotherapy of alcohol dependence: a state of the art review.Short-term neuropsychological recovery in clients with substance use disorders.The role of Alcoholics Anonymous in mobilizing adaptive social network changes: a prospective lagged mediational analysis.Client-Provider relationship in comprehensive substance abuse treatment: differences in residential and nonresidential settings.Using mathematical modeling and control to develop structured treatment interruption strategies for HIV infection.Systematic review of the pharmacological treatment of alcohol use disorders in individuals infected with hepatitis C.Pharmacotherapy for alcohol dependence: anticraving medications for relapse prevention.Modafinil and sleep architecture in an inpatient-outpatient treatment study of cocaine dependenceOxford recovery housing: Length of stay correlated with improved outcomes for women previously involved with the criminal justice system.The therapeutic potential of small-conductance KCa2 channels in neurodegenerative and psychiatric diseasesConcurrent brief versus intensive smoking intervention during alcohol dependence treatmentOutpatient alcoholism treatment--24-month outcome and predictors of outcomeExtending residential care through telephone counseling: initial results from the Betty Ford Center Focused Continuing Care protocol.Predictors of drinking and functional outcomes for men and women following inpatient alcohol treatmentNew Perspectives in the Exploration of Korsakoff's Syndrome: The Usefulness of Neurophysiological MarkersIbogaine and addiction in the animal model, a systematic review and meta-analysis.Abstinence at Successful Discharge in Publicly Funded Addiction Health Services.Effects of Treatment Type on Alcohol Consumption Partially Mediated by Alcoholics Anonymous Attendance.Efficacy of an intensive outpatient rehabilitation program in alcoholism: predictors of outcome 6 months after treatment.A randomised clinical trial of in-patient versus combined day hospital treatment of alcoholism: primary and secondary outcome measures.Determinants of relapse and re-admission among alcohol abusers after intensive residential treatment.Preclinical evaluation of avermectins as novel therapeutic agents for alcohol use disorders.Randomized clinical trial of matching client alcohol use disorder severity and level of cognitive functioning to treatment setting: A partial replication and extension.Alcoholic liver diseaseAlcohol- and drug-use disorders in Australia: implications of the National Survey of Mental Health and WellbeingAlcoholics' Evaluations of Alcoholism Treatment
P2860
Q24613295-0FFD2EB3-C5B0-452A-9C35-A95C2925E500Q30434793-ECF1AD80-0A89-4637-A2D6-645514891A64Q30440516-B79662F2-7EAE-41F0-B43A-3211B23C8BF7Q30443459-CF7255E4-0899-43B2-9EDA-A59166D8801BQ33557370-8A63A3DE-7D5F-424E-A532-4F30F2935A41Q33719351-E75BA33B-FBFE-434B-B0A6-D9266511275EQ33774093-E99F5D2E-7B26-4510-A0D9-D1261788A061Q33811745-A590B36A-7D19-4BE5-97C5-11DE6B7A1622Q34125417-2B5B26E3-1118-43F4-B36A-86874D852BD6Q34233408-3BB633E3-E12C-4F80-8156-B500D235FEE0Q34543952-E15F6B59-7123-4B20-BD29-6977A9B0B8A3Q34690585-C42D54B2-05BD-421B-A735-149880A9BA1FQ34708991-7E23910A-9C1A-429F-87C0-F79EB7EF637DQ35490338-E6DDDEC2-5CAC-425A-9FC0-D8BF52AE3EE8Q36026242-6F1FD214-8A41-4D72-8D37-BB3E93522E96Q36259199-B8822600-671E-4730-B1AF-51B0EFF66384Q36461774-98690517-10F5-4A43-82A2-DFC2072C1AFDQ36619373-28133AF8-F1D3-467F-B811-8C203E636D22Q36781878-E880E1F7-8954-46E0-A693-81977690B2A0Q37185277-80461136-9883-4BC0-A2FA-8DE20D12E7B5Q37242037-C16B7420-69E6-4C2D-8666-5E9E90601FE6Q37274057-2FB82B07-05BC-4917-BCA6-746C7989D095Q37328731-F86D1F09-30B9-4C9A-8CA7-D045AE87DC55Q37702767-C6DE7C8E-A01A-4307-9ECC-DED44C306D5DQ38466033-8FF3DEED-F097-4231-AEB7-AC3854EA55B8Q38849032-06CD5670-2B02-467F-AB86-307CF4286CB1Q41646052-7FF5A816-1885-49AA-9C12-533C0382E9E0Q46087325-FE657863-BC3D-482F-9BA6-BF7E1B34DD17Q46577342-437E82A6-B2F3-449F-AE97-2C461ADC224FQ46658668-B56A41F7-D0D1-4FE3-B970-FD7DBBB9923CQ46912572-47928B12-1741-4E05-A6AE-41D43B2F3D59Q52316040-2A2B2DBF-0186-4372-92BA-0760A4818C8CQ53532687-7E914FFE-AF15-4534-9FE5-939DC8B46F5CQ56004976-ECB115A6-0C97-4F84-94E2-6804B13A3CA4Q57047876-67FF6D71-1379-4B7A-926C-4E94D03656C4Q58108457-EF18E15E-3400-4EE4-BCE9-CF5C5C8E56F5
P2860
The effectiveness of inpatient and outpatient treatment for alcohol abuse: the need to focus on mediators and moderators of setting effects.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
The effectiveness of inpatient ...... moderators of setting effects.
@en
type
label
The effectiveness of inpatient ...... moderators of setting effects.
@en
prefLabel
The effectiveness of inpatient ...... moderators of setting effects.
@en
P2093
P1433
P1476
The effectiveness of inpatient ...... moderators of setting effects.
@en
P2093
P304
1773-96; discussion 1803-20
P356
10.1046/J.1360-0443.1996.911217733.X
P407
P577
1996-12-01T00:00:00Z